biote Corp.
For the period ended Dec 31, 2025. Filed Mar 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 13, 2026
BTMD$1.08-2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity (Deficit)
| Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated · Stockholders’ | |||||||||||
| Additional · Other · Deficit · Non- · Total | |||||||||||
| Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’ | |||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Loss | Stock | biote Corp. | Interest | Deficit | |
| Balance at December 31, 2024 | 31,485,777 | $3 | 5,221,653 | $1 | $— | $(100,297) | $(35) | $(5,600) | $(105,928) | $3,728 | $(102,200) |
| Distributions | — | — | — | — | — | — | — | — | — | (1,727) | (1,727) |
| Net income (loss) | — | — | — | — | — | 27,045 | — | — | 27,045 | 4,552 | 31,597 |
| Other comprehensive income | — | — | — | — | — | — | 6 | — | 6 | — | 6 |
| Share-based compensation | — | — | — | — | — | 8,921 | — | — | 8,921 | — | 8,921 |
| Vesting of RSUs | 24,039 | — | — | — | — | (566) | — | — | (566) | 566 | — |
| Issuance of stock under purchase plans | 54,002 | — | — | — | — | (205) | — | — | (205) | 347 | 142 |
| Exercise of stock options | 64,040 | — | — | — | — | (436) | — | — | (436) | 662 | 226 |
| Common stock repurchased | (1,011,767) | — | — | — | — | — | — | (3,365) | (3,365) | — | (3,365) |
| Shares issued in connection with acquisition | 97,276 | — | — | — | — | (14) | — | — | (14) | 14 | — |
| Legal Settlement - Liabilities | — | — | — | — | — | 15,977 | — | — | 15,977 | — | 15,977 |
| TRA liability | — | — | — | — | — | 26 | — | — | 26 | — | 26 |
| Balance at December 31, 2025 | 30,713,367 | $3 | 5,221,653 | $1 | $— | $(49,549) | $(29) | $(8,965) | $(58,539) | $8,142 | $(50,397) |
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
| Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated · Stockholders’ | |||||||||||
| Additional · Other · Deficit · Non- · Total | |||||||||||
| Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’ | |||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Loss | Stock | biote Corp. | Interest | Deficit | |
| Balance at December 31, 2023 | 34,254,883 | $3 | 28,819,066 | $3 | $— | $(29,391) | $(12) | $— | $(29,397) | $(7,149) | $(36,546) |
| Distributions | — | — | — | — | — | — | — | — | — | (4,744) | (4,744) |
| Net income (loss) | — | — | — | — | — | 3,157 | — | — | 3,157 | (3,111) | 46 |
| Other comprehensive income | — | — | — | — | — | — | (18) | — | (18) | (4) | (22) |
| Share-based compensation | — | — | — | — | — | 8,735 | — | — | 8,735 | — | 8,735 |
| Vesting of RSUs | 444,783 | — | — | — | — | (17,959) | (7) | — | (17,966) | 17,966 | — |
| Issuance of stock under purchase plans | 63,413 | — | — | — | — | (836) | — | — | (836) | 1,118 | 282 |
| Exercise of stock options | 556,515 | — | — | — | — | (2,140) | (1) | — | (2,141) | 4,531 | 2,390 |
| Class A common stock repurchased | (996,964) | — | — | — | — | — | — | (5,599) | (5,599) | — | (5,599) |
| Shares issued in connection with acquisition | 291,829 | — | — | — | — | 1,146 | — | — | 1,146 | 695 | 1,841 |
| Exchanges of Class V voting stock | 1,946,408 | — | (1,946,408) | — | — | 3,656 | 2 | — | 3,658 | (3,658) | — |
| Legal Settlement - Repurchase of Shares | (5,075,090) | — | (21,651,005) | (2) | — | (126,498) | 1 | (1) | (126,500) | (1,916) | (128,416) |
| Legal Settlement - Liabilities | — | — | — | — | — | 59,074 | — | — | 59,074 | — | 59,074 |
| TRA liability | — | — | — | — | — | 759 | — | — | 759 | — | 759 |
| Balance at December 31, 2024 | 31,485,777 | $3 | 5,221,653 | $1 | $— | $(100,297) | $(35) | $(5,600) | $(105,928) | $3,728 | $(102,200) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.